ESR1 and breast cancer: In contrast, Kastrati et al. have revealed that miR-181 overexpression inhibits estrogen receptor (ER)+ BC tumor growth by downregulating pleckstrin homology-like domain, family A, member 1 (PHLDA1), a key protein in stem cell maintenance and cell survival [108].